Trials / Completed
CompletedNCT03043287
Voiding Efficiency, a Predictor of Clean Intermittent Catheterization (CIC)
Voiding Efficiency, a Predictor of CIC
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 420 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a retrospective chart review of patients treated with onabotulinumtoxinA (BOTOX®) for idiopathic overactive bladder (OAB) and will determine voiding efficiency (VE) cutoff ratios that predict post-procedure urinary retention requiring catheterization.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | onabotulinumtoxinA | onabotulinumtoxinA (BOTOX®)100 to 200 U |
Timeline
- Start date
- 2017-05-12
- Primary completion
- 2019-09-09
- Completion
- 2019-09-30
- First posted
- 2017-02-06
- Last updated
- 2020-02-05
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03043287. Inclusion in this directory is not an endorsement.